Chemical modification of the prototype CB1R ago-PAM, GAT211, yielded new CB1R allosteric modulators (−)-(S,R)-13 and (+)-(R,S)-14, which showed significant bias for CB1R signaling pathways, as supported by docking studies. Compound 14 efficiently lowered elevated intraocular pressure when it is due to an increase in endocannabinoid tone. This article may open new avenues to meet the therapeutic needs presented by glaucoma.
Corelli, F. (2021). Has a “Chemical Magic” Opened up New Prospects for Glaucoma?. JOURNAL OF MEDICINAL CHEMISTRY, 64(12), 8101-8103 [10.1021/acs.jmedchem.1c00843].
Has a “Chemical Magic” Opened up New Prospects for Glaucoma?
FEDERICO CORELLI
2021-01-01
Abstract
Chemical modification of the prototype CB1R ago-PAM, GAT211, yielded new CB1R allosteric modulators (−)-(S,R)-13 and (+)-(R,S)-14, which showed significant bias for CB1R signaling pathways, as supported by docking studies. Compound 14 efficiently lowered elevated intraocular pressure when it is due to an increase in endocannabinoid tone. This article may open new avenues to meet the therapeutic needs presented by glaucoma.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
P_227_JMC.pdf
non disponibili
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
678.92 kB
Formato
Adobe PDF
|
678.92 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/11365/1173087